The running joke about Part 15 hearings is that they're so named because there are generally only 15 interesting minutes. Not so for the upcoming Part 15 hearing on social media. Good topic. Timely topic. Sexy topic.
And the list of those testifying is also a guarantee of better-than-usual fare. That list (subject to change) can be found here.
Pharmaceutical marketers and the FDA are in a tough spot when it comes to social media. On the one hand, both recognize the importance of and opportunity in it. It's where the people are. It's where the action is. On the other hand there are those pesky regulatory concerns.
To quote that well-known FDA pundit -- Buffalo Springfield -- "There's something happening here. What it is ain't exactly clear."
And clarity (qua predictability) is the key to success for social media to become a powerful tool in advancing both marketing aims as well as the public health. Not mutually exclusive goals -- and not necessarily in that order.
And the list of those testifying is also a guarantee of better-than-usual fare. That list (subject to change) can be found here.
Pharmaceutical marketers and the FDA are in a tough spot when it comes to social media. On the one hand, both recognize the importance of and opportunity in it. It's where the people are. It's where the action is. On the other hand there are those pesky regulatory concerns.
To quote that well-known FDA pundit -- Buffalo Springfield -- "There's something happening here. What it is ain't exactly clear."
And clarity (qua predictability) is the key to success for social media to become a powerful tool in advancing both marketing aims as well as the public health. Not mutually exclusive goals -- and not necessarily in that order.
